Centessa Pharmaceuticals plc — Director's Dealing 2023

Jul 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2023-06-30

Reporting Person: Weinhoff Gregory M (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-30	Ordinary Shares	F	11742	$5.9001	Disposed	280581	Direct

Footnotes

F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.